| HOME >> MEDICINE >> TECHNOLOGY |
177
178Additional paid-in capital
146,396
145,381Accumulated deficit
(164,271)
(157,334)Total stockholders’ deficit
(17,698)
(11,775)Total liabilities and stockholders’ deficit
$
30,006
$
33,196ARCADIA RESOURCES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)Three Month Period Ended September 30, Six Month Period Ended September 30, (Unaudited)(Unaudited)2010200920102009Services
$
20,931
$
21,709$
41,295
$
44,389Pharmacy
4,911
3,4089,965
6,625Revenues, net
25,842
25,11751,260
51,014Cost of revenues
18,797
17,92337,453
36,549Gross profit
7,045
7,19413,807
14,465Selling, general and administrative
9,581
9,87819,315
19,329Depreciation and amortization
326
531634
942Total operating expenses
9,907
10,40919,949
20,271Operating loss
(2,862)
(3,215)(6,142)
(5,806)Other expenses:Interest expense, net
980
8461,823
1,684Change in fair value of warrant liability
(779)
-(137)
-Other
-
(6)-
30Total other expenses
201
8401,686
1,714Loss from continuing operations before income taxes
(3,063)
(4,055)(7,828)
(7,520)Income tax expense
40
773
100Loss from continuing operations
(3,103)
(4,062)(7,901)
(7,620)Discontinued operations:Loss from discontinued operations
(52)
(248)(82)
(1,477)Net gain on disposal
259
1631,046
379207
(85)964
(1,098)NET LOSS
$
(2,896)
$
(4,147)$
(6,937)
$
(8,718)Weighted average number of commo
'/>"/>
| SOURCE Arcadia Resources, Inc. Copyright©2010 PR Newswire. All rights reserved |